drugset / Trial / NCT00472966

Efficacy and Safety of Therapy With Tri-Luma® Cream in Sequence With Glycolic Acid Peels for Melasma

NCT00472966

Phase 4 Completed 20 enrolled Galderma R&D
Non-randomizedSingle-groupOpen-labelTreatment

Summary

To determine the effectiveness and safety of sequential therapy with of Tri-Luma® Cream and a series of Glycolic Acid peels in treatment of moderate to severe melasma.

Timeline

Start
2006-11
Primary completion
2007-04
Completion
2007-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Glycolic acid Small molecule
Subject Hydroquinone Small molecule 4 % Topical
Subject Tretinoin Small molecule 0.05 % Topical
Subject fluocinolone acetonide Small molecule 0.1 % Topical